Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học quốc tế đề tài :Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer | Journal of Translational Medicine BioMed Central Research Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer Alessandro Passardi 1 Lorenzo Cecconetto1 Monia Dall Agata2 Claudio Dazzi3 Enzo Pasquini4 Giovanni Oliverio4 Federica Zumaglini3 Wainer Zoli1 Oriana Nanni2 Carlo Milandri1 Giovanni Luca Frassineti1 and Dino Amadori1 Address 1Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola Italy 2Istituto Oncologico Romagnolo Forlì Italy 3Department of Oncology Santa Maria delle Croci Hospital Ravenna Italy and 4Department of Oncology Infermi Hospital Rimini Italy Email Alessandro Passardi - sandropass@ Lorenzo Cecconetto - lorenzocecco@ Monia Dall Agata - Claudio Dazzi - Enzo Pasquini - oncologiacattolica@ Giovanni Oliverio - goliverio@ Federica Zumaglini - Wainer Zoli - Oriana Nanni - Carlo Milandri - cmilandri@ Giovanni Luca Frassineti - Dino Amadori - segronco@ Corresponding author Open Access Published 31 October 2008 Received 7 July 2008 ZT. -nnr zzr J nz . z-rn rn-rz z z r Accepted 31 October 2008 Journal of Translational Medicine 2008 6 65 doi 1479-5876-6-65 This article is available from http content 6 1 65 2008 Passardi et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Docetaxel and gemcitabine combinations have proven active for the treatment of non-small cell lung cancer NSCLC . The aim of the present study was to evaluate and compare two treatment schedules
